1. Institut Pasteur (11 from 869 patents)

2. Centre National De La Recherche Scientifique (5 from 5,069 patents)

3. Institut National De La Sante Et De La Recherche Medicale (4 from 1,743 patents)

4. Commissariat À L'Énergie Atomique Et Aux Énergies Alternatives (2 from 4,868 patents)

5. Université Grenoble Alpes (1 from 152 patents)

6. Université Paris—sud (1 from 99 patents)

7. Centre National De La Recherche Scientifique-cnrs (65 patents)

8. Université Paris-Sud 11 (42 patents)

9. Inserm (institut National De La Sante Et De La Recherche Medicale) (36 patents)

10. Université Paris Sud Xi (23 patents)

11. Inserm (0 patent)

1. 11884708 - Stapled peptide inhibitors of nemo as potential anti-inflammatory and anti-cancer drugs

2. 11472844 - Peptidomimetics, method of synthesis and uses thereof

3. 11149070 - Stapled peptide inhibitors of NEMO as potential anti-inflammatory and anti-cancer drugs

4. 10138280 - Polypeptides targeting glycosylated MUC2 proteins, methods of synthesis, their nucleic acids and uses thereof

5. 9907860 - Conjugated molecules comprising a peptide derived from the CD4 receptor coupled to an anionic polypeptide for the treatment of AIDS

6. 9446109 - [object Object]

7. 9382299 - Polypeptides targeting glycosylated MUC2 proteins, methods of synthesis, their nucleic acids and uses thereof

8. 9295730 - Conjugated molecules comprising a peptide derived from the CD4 receptor coupled to a polyanion for the treatment of AIDS

9. 9078928 - Conjugated molecules comprising a peptide derived from the CD4 receptor coupled to a polyanionic polypeptide for the treatment of AIDS

10. 8124380 - [object Object]

11. 7820142 - Immunogenic glycopeptides, screening, preparation and uses

12. 7700553 - Selective inhibition of NF-κB activation by peptides designed to disrupt nemo oligomerization